Chronic liver disorders (CLDs) affect roughly 844 million people worldwide, and result in the deaths of about two million people each year. GIOSTAR recently conducted research pointing to the potential benefit of stem cell therapy in addressing this epidemic.
Tag: stem cell therapy
Are you suffering from neuropathy? Stem cell therapy is showing promise as a solution for neuropathic pain. Learn more here.
Dr. Anand Srivastava, Deven Patel, Dr. Amy Killen, and Dr. Kyle Bergquist take part in a fascinating mini-documentary entitled Age of Cells. The program features extensive interviews with Dr. Srivastava and Mr. Patel, excerpts from lectures, and a sweeping tour of India.
Under the direction of GIOSTAR Co-Founder Dr. Anand Srivastava, a patient was treated with a topical application of mesenchymal stem cells. Remarkably, the patient saw their psoriasis regress completely after only one month.
GIOSTAR Co-Founder Dr. Anand Srivastava discusses his ground-breaking research on creating red blood cells from stem cells. This innovation has the potential to eradicate diseases worldwide by solving three central problems with blood transfusion.
In the latest GIOTalk episode, Dr. Gellis speaks with Dr. Jonathan Maks, Doctor of Internal Medicine and Regional Medical Director of AMITA Health Medical Group (AHMG). They discuss trends in patient care, including the increased adoption of technology in medicine, the decline in physician-owned medical practices, and a marked shift in the tenor of interactions between patients and their doctors.
Under the direction of Dr. Srivastava, the patient was treated with Mesenchymal Stem Cell Conditioned Media (MSC-CM), which was applied topically to affected areas daily. Remarkably, after only one month, the patient saw their psoriasis regress completely.
Dr. Gellis continues his insightful discussion with Dr. Anand Srivastava about the ever-evolving landscape of regenerative medicine.
This installment of GIOTalk features a helpful overview of Dr. Anand Srivastava’s ground-breaking discoveries in the field of stem cell research, along with his views on the future of regenerative medicine.